Lipoproteins act as vehicles for lipid antigen delivery and activation of invariant natural killer T cells

Lipoproteins act as vehicles for lipid antigen delivery and activation of invariant natural killer T cells

Invariant natural killer T (iNKT) cells act at the interface between lipid metabolism and immunity because of their restriction to lipid antigens presented on CD1d by antigen-presenting cells (APCs). How foreign lipid antigens are delivered to APCs remains elusive. Since lipoproteins routinely bind...

Detaylı Bibliyografya
Asıl Yazarlar:	Engelen, SE, Ververs, FA, Markovska, A, Lagerholm, BC, Kraaijenhof, JM, Yousif, LI, Zurke, Y-X, Gulersonmez, CM, Kooijman, S, Goddard, M, van Eijkeren, RJ, Jervis, PJ, Besra, GS, Haitjema, S, Asselbergs, FW, Kalkhoven, E, Ploegh, HL, Boes, M, Cerundolo, V, Hovingh, GK, Salio, M, Stigter, EC, Rensen, PC, Monaco, C, Schipper, HS
Materyal Türü:	Journal article
Dil:	English
Baskı/Yayın Bilgisi:	American Society for Clinical Investigation 2023

Benzer Materyaller

Lipoproteins act as vehicles for lipid antigen delivery and activation of invariant natural killer T cells
Yazar:: Suzanne E. Engelen, ve diğerleri
Baskı/Yayın Bilgisi: (2023-05-01)

Cytokine Output of Adipocyte-iNKT Cell Interplay Is Skewed by a Lipid-Rich Microenvironment
Yazar:: Robert J. van Eijkeren, ve diğerleri
Baskı/Yayın Bilgisi: (2020-07-01)

Synthesis of truncated analogues of the iNKT cell agonist, α-galactosyl ceramide (KRN7000), and their biological evaluation
Yazar:: Veerapen, N, ve diğerleri
Baskı/Yayın Bilgisi: (2011)

Synthesis of truncated analogues of the iNKT cell agonist, α-galactosyl ceramide (KRN7000), and their biological evaluation.
Yazar:: Veerapen, N, ve diğerleri
Baskı/Yayın Bilgisi: (2011)

Immunometabolic factors in adolescent chronic disease are associated with Th1 skewing of invariant Natural Killer T cells
Yazar:: Ververs, FA, ve diğerleri
Baskı/Yayın Bilgisi: (2021)

Towards multivalent CD1d ligands: Synthesis and biological activity of homodimeric α-galactosyl ceramide analogues
Yazar:: Jervis, P, ve diğerleri
Baskı/Yayın Bilgisi: (2012)

Towards multivalent CD1d ligands: synthesis and biological activity of homodimeric α-galactosyl ceramide analogues.
Yazar:: Jervis, P, ve diğerleri
Baskı/Yayın Bilgisi: (2012)

Therapeutic strategies targeting inflammation and immunity in atherosclerosis: how to proceed?
Yazar:: Engelen, SE, ve diğerleri
Baskı/Yayın Bilgisi: (2022)

Immunometabolic factors in adolescent chronic disease are associated with Th1 skewing of invariant Natural Killer T cells
Yazar:: Francesca A. Ververs, ve diğerleri
Baskı/Yayın Bilgisi: (2021-10-01)

Invariant NKT Cell at the Interface between Innate and Adaptive Immunity
Yazar:: Salio, M, ve diğerleri
Baskı/Yayın Bilgisi: (2011)

Linking inflammation to natural killer T cell activation
Yazar:: Salio, M, ve diğerleri
Baskı/Yayın Bilgisi: (2009)

Harnessing NKT cells for therapeutic applications.
Yazar:: Cerundolo, V, ve diğerleri
Baskı/Yayın Bilgisi: (2007)

Viral immunity: cross-priming with the help of TLR3.
Yazar:: Salio, M, ve diğerleri
Baskı/Yayın Bilgisi: (2005)

Linking inflammation to natural killer T cell activation.
Yazar:: Mariolina Salio, ve diğerleri
Baskı/Yayın Bilgisi: (2009-10-01)

Proteomic Signatures of Genetically Predicted and Pharmacologically Observed PCSK9 Inhibition
Yazar:: Jordan M. Kraaijenhof, ve diğerleri
Baskı/Yayın Bilgisi: (2024-06-01)

Targeted inhibition of glycogen synthase kinase-3 using 9-ING-41 (elraglusib) enhances CD8 T-cell-reactivity against neuroblastoma cells
Yazar:: A. Markovska, ve diğerleri
Baskı/Yayın Bilgisi: (2024-09-01)

Impaired selection of invariant natural killer T cells in diverse mouse models of glycosphingolipid lysosomal storage diseases.
Yazar:: Gadola, S, ve diğerleri
Baskı/Yayın Bilgisi: (2006)

Modulation of human natural killer T cell ligands on TLR-mediated antigen-presenting cell activation.
Yazar:: Salio, M, ve diğerleri
Baskı/Yayın Bilgisi: (2007)

Harnessing the power of invariant natural killer T cells in cancer immunotherapy
Yazar:: Bedard, M, ve diğerleri
Baskı/Yayın Bilgisi: (2017)

The immune modulating properties of mucosal-associated invariant T cells
Yazar:: Ioannidis, M, ve diğerleri
Baskı/Yayın Bilgisi: (2020)

Dendritic cell maturation is induced by mycoplasma infection but not by necrotic cells.
Yazar:: Salio, M, ve diğerleri
Baskı/Yayın Bilgisi: (2000)

T cell receptors get back to basics.
Yazar:: Jones, E, ve diğerleri
Baskı/Yayın Bilgisi: (2007)

Dendritic cells: a journey from laboratory to clinic.
Yazar:: Cerundolo, V, ve diğerleri
Baskı/Yayın Bilgisi: (2004)

Recent advances in processing and presentation of CD1 bound lipid antigens.
Yazar:: Salio, M, ve diğerleri
Baskı/Yayın Bilgisi: (2010)

The Immune Modulating Properties of Mucosal-Associated Invariant T Cells
Yazar:: Melina Ioannidis, ve diğerleri
Baskı/Yayın Bilgisi: (2020-08-01)

Harnessing the Power of Invariant Natural Killer T Cells in Cancer Immunotherapy
Yazar:: Melissa Bedard, ve diğerleri
Baskı/Yayın Bilgisi: (2017-12-01)

A single-cell genomic based investigation of immune cells in the aorta and adipose tissue during metabolic disease progression
Yazar:: Zurke, YX
Baskı/Yayın Bilgisi: (2023)

Design, synthesis, and functional activity of labeled CD1d glycolipid agonists.
Yazar:: Jervis, P, ve diğerleri
Baskı/Yayın Bilgisi: (2013)

The year in cardiovascular medicine 2020: digital health and innovation [Год в сердечно-сосудистой медицине, 2020 г.: цифровое здравоохранение и инновации]
Yazar:: Antoniades, C, ve diğerleri
Baskı/Yayın Bilgisi: (2021)

Harnessing invariant NKT cells in vaccination strategies.
Yazar:: Cerundolo, V, ve diğerleri
Baskı/Yayın Bilgisi: (2009)

Valpha24-JalphaQ-independent, CD1d-restricted recognition of alpha-galactosylceramide by human CD4(+) and CD8alphabeta(+) T lymphocytes.
Yazar:: Gadola, S, ve diğerleri
Baskı/Yayın Bilgisi: (2002)

B cell receptor-mediated uptake of CD1d-restricted antigen augments antibody responses by recruiting invariant NKT cell help in vivo.
Yazar:: Barral, P, ve diğerleri
Baskı/Yayın Bilgisi: (2008)

Essential role for autophagy during invariant NKT cell development
Yazar:: Salio, M, ve diğerleri
Baskı/Yayın Bilgisi: (2014)

Potential role for CD1d restricted T-cells in the immunopathology of sarcoidosis
Yazar:: Ho, L, ve diğerleri
Baskı/Yayın Bilgisi: (2003)

Immunotherapy of colorectal cancer.
Yazar:: Smith, C, ve diğerleri
Baskı/Yayın Bilgisi: (2002)

A closer look at CD1d molecules: new horizons in studying NKT cells.
Yazar:: Stronge, V, ve diğerleri
Baskı/Yayın Bilgisi: (2007)

The use of HLA class I tetramers to design a vaccination strategy for melanoma patients.
Yazar:: Palmowski, M, ve diğerleri
Baskı/Yayın Bilgisi: (2002)

Biology of CD1- and MR1-restricted T cells.
Yazar:: Salio, M, ve diğerleri
Baskı/Yayın Bilgisi: (2014)

Lipid-modifying agents, from statins to PCSK9 inhibitors: JACC focus seminar
Yazar:: Preiss, D, ve diğerleri
Baskı/Yayın Bilgisi: (2020)

Expression of MHC class I-related Chain B (MICB) molecules on renal transplant biopsies.
Yazar:: Quiroga, I, ve diğerleri
Baskı/Yayın Bilgisi: (2006)